If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
UROLOGY
ISSN 2053-4213 April 2013 • emjreviews.com
INSIDE
Review of the
28th EAU Annual Congress
Milan, Italy
UROLOGY
contents
EDITORIAL PANEL 4
CONGRESS REVIEW 8
• Review of the 29th EAU Annual Congress held in Milan, Italy, 15th-19th March 2013
BURDEN OF ILLNESS AND OPTIMAL MANAGEMENT OF RECURRENT CYSTITIS 23
• Florian Wagenlehner, Kurt Naber, Bjorn Wullt, Peter Tenke
INCREASING EVIDENCE OF EFFECTIVENESS OF GAG THERAPY IN DIFFERENT FORMS OF CYSTITIS 35
• Pier Francesco Bassi, Mauro Cervigni, Enrico Finazzi Agrò, Rocco Damiano, Roman Tomaškin
TOWARDS INDIVIDUALISATION OF PR
UROLOGY ISSN 2053-4213
UROLOGY contents EDITORIAL PANEL
PRACTICE PATTERNS FOR IMPROVING OUTCOMES IN WOMEN
UROLOGY Editorial Panel Dr. Abdullah Erdem Canda
UROLOGY Publisher Claire Gore Editorial Direc
6 UROLOGY • April 2013
Foreword Evangelos Liatsikos, M.D, Ph.D Associate
EAU ANNUAL CONGRESS 2013 MILANO CONGRESSI, MILAN,
Welcome to the European Medical Journal review of
EAU ANNUAL CONGRESS 2013 MILANO CONGRESSI, MILAN,
EW OF THE 28TH ANNUAL EUROPEAN ASSOCIATION OF CON
EAU ANNUAL CONGRESS 2013 MILANO CONGRESSI, MILAN,
ANTIBIOTIC ‘TIME BOMB’ KEEPS TICKING RISK of inf
EAU ANNUAL CONGRESS 2013 MILANO CONGRESSI, MILAN,
EXTERNAL INFLUENCES HAVE POTENTIALLY KEY ROLE IN
EAU ANNUAL CONGRESS 2013 MILANO CONGRESSI, MILAN,
organs taken when placing the patient in the same
EAU ANNUAL CONGRESS 2013 MILANO CONGRESSI, MILAN,
E TREATMENTS FOR ANDROLOGY usu
EAU ANNUAL CONGRESS 2013 MILANO CONGRESSI, MILAN,
NOCTURIA CAUSES 25% LOWER WORK PRODUCTIVITY PEOP
Burden of Illness and Optimal Management of
EAU CONGRESS REVIEW ECO.SENS – 2003/11 N.-Europe
BURDEN OF ILLNESS AND OPTIMAL MANAGEMENT OF RECUR
EAU CONGRESS REVIEW 40% of women will experience
BURDEN OF ILLNESS AND OPTIMAL MANAGEMENT OF RECUR
EAU CONGRESS REVIEW uroepithelial lining and the
BURDEN OF ILLNESS AND OPTIMAL MANAGEMENT OF RECUR
EAU CONGRESS REVIEW pre-menopausal women (15–5
BURDEN OF ILLNESS AND OPTIMAL MANAGEMENT OF RECUR
EAU CONGRESS REVIEW (oflaxacin, ciprofloxacin, amp
BURDEN OF ILLNESS AND OPTIMAL MANAGEMENT OF RECUR
Increasing Evidence of Effectiveness of G
INCREASING EVIDENCE OF EFFECTIVENESS OF GAG THERA
EAU CONGRESS REVIEW Various clinical trials have
INCREASING EVIDENCE OF EFFECTIVENESS OF GAG THERA
EAU CONGRESS REVIEW occurrence of breakthrough i
INCREASING EVIDENCE OF EFFECTIVENESS OF GAG THERA
EAU CONGRESS REVIEW from clinically symptomatic
INCREASING EVIDENCE OF EFFECTIVENESS OF GAG THERA
TOWARDS INDIVIDUALISATION OF PROSTATE CANCER 4,3
EAU CONGRESS REVIEW treatment to be targeted. Fo
TOWARDS INDIVIDUALISATION OF PROSTATE CANCER
EAU CONGRESS REVIEW target is the rapamycin (mTO
TOWARDS INDIVIDUALISATION OF PROSTATE CANCER 1%-
EAU CONGRESS REVIEW ml was defined as the ‘normal
TOWARDS INDIVIDUALISATION OF PROSTATE CANCER
EAU CONGRESS REVIEW The use of percentage pro PS
TOWARDS INDIVIDUALISATION OF PROSTATE CANCER enz
EAU CONGRESS REVIEW Progression free survival (
TOWARDS INDIVIDUALISATION OF PROSTATE CANCER inc
EAU CONGRESS REVIEW with IMRT/3D-CRT) or brachyt
TOWARDS INDIVIDUALISATION OF PROSTATE CANCER REF
EAU CONGRESS REVIEW 40. Scher HI, Fizazi K, Saad
The new Verify™ System is now available Th disc
TRANSURETHRAL RESECTION OF BLADDER TUMOUR: HOW TO
EAU CONGRESS REVIEW detected, there was less res
TRANSURETHRAL RESECTION OF BLADDER TUMOUR: HOW TO
EAU CONGRESS REVIEW The limitations observed in t
TRANSURETHRAL RESECTION OF BLADDER TUMOUR: HOW TO
EAU CONGRESS REVIEW Blue-Light and Managemen
TRANSURETHRAL RESECTION OF BLADDER TUMOUR: HOW TO
EAU CONGRESS REVIEW trial, with an overall follo
TRANSURETHRAL RESECTION OF BLADDER TUMOUR: HOW TO
EAU CONGRESS REVIEW months) in the immediate sin
TRANSURETHRAL RESECTION OF BLADDER TUMOUR: HOW TO
EAU CONGRESS REVIEW 28. Shen P,Yang J,Wei W, et
MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNO
protein and RNA-based studies. Numerous studies t
FMEUMLTAILPELESXEXURAINLADRYSFTUENSTCSTIFONRSBALN
VIRGINIA URQUIDI ET AL. P, Juusela H, et al. Dif
PRACTICE PATTERNS FOR IMPROVING OUTCOMES IN
various factors that may impair outcomes. A good
PRACTICE PATTERNS FOR IMPROVING OUTCOMES IN WOMEN
GEORGIOS GAKIS CONCLUSION
PROSTATIC INFLAMMATION IS DETERMINANT FOR PR
INTRODUCTION Benign prostatic hyperplasia (BPH),
PROSTATIC INFLAMMATION IS DETERMINANT FOR PROSTAT
MAURO GACCI ET AL. prostatectomy for severe LUTS
PROSTATIC INFLAMMATION IS DETERMINANT FOR PROSTAT
NEUROENDOCRINE TUMOUR OF THE PROSTATE:
NEUROENDOCRINE TUMOUR OF THE PROSTATE: A RARE VAR
OZER URAL CAKICI ET AL. carcinomas are detected
NEUROENDOCRINE TUMOUR OF THE PROSTATE: A RARE VAR
PREDICTING REFRACTORY DETRUSOR OVERACTIVITY:
PREDICTING REFRACTORY DETRUSOR OVERACTIVITY: ARE
KYLIE MANSFIELD ET AL. Patient history of bacter
PREDICTING REFRACTORY DETRUSOR OVERACTIVITY: ARE
KYLIE MANSFIELD ET AL. CONCLUSION Results from t
FEMALE SEXUAL DYSFUNCTIONS AND UROGYNECOLOGICA
studies have investigated FSF using the Female Se
FEMALE SEXUAL DYSFUNCTIONS AND UROGYNECOLOGICAL D
EMILIO SACCO, DANIELE TIENFORTI POP and FSD.74-7
FEMALE SEXUAL DYSFUNCTIONS AND UROGYNECOLOGICAL D
EMILIO SACCO, DANIELE TIENFORTI women with sexua
FEMALE SEXUAL DYSFUNCTIONS AND UROGYNECOLOGICAL D
EMILIO SACCO, DANIELE TIENFORTI female sexual fu
LOWER POLE CALYCEAL STONE AND LITHOTRIPSY - ARE
endocasts of the pelvicaliceal system. They obser
LOWER POLE CALYCEAL STONE AND LITHOTRIPSY - ARE I
M. HAMMAD ATHER REFERENCES 1 Trinchieri A. Epide
WHAT’S NEW SMARTPHONE APP TESTS URINE FOR MEDICA
UROLOGY EU REGULATOR APPROVES ZYTIGA BEFORE CHEM
WHAT’S NEW FDA CLEARS ALLERGAN’S BOTOX TO TREAT
UROLOGY GENETIC ALTERATIONS CAN IDENTIFY BLADDER
WHAT’S NEW IMMUNE MEMORY DEFECT MAY CAUSE REPEAT
UROLOGY NEW TREATMENT OPTION FOR OVERACTIVE BLADD
WHAT’S NEW COENZYME Q10 SUPPLEMENT MAY BOOST MAL
www.emjreviews.com From a host of fourteen ther
FEATUREDSUPPLIERS A.M.I GMBH
UROLOGY 2013 KLS MARTIN GROUP
FEATUREDSUPPLIERS TRISTEL SOLUTIONS
www.issmessm2013.org JOIN US IN BERLIN !
UPCOMING EVENTS & CONGRESSES 6th EAU Leading Li
UROLOGY 3rd International Meeting “Challenges i
From a host of fourteen therapeutical areas, EURO